Talk:Temozolomide

From Wikipedia, the free encyclopedia

This is the talk page for discussing improvements to the Temozolomide article.
Please sign and date your posts by typing four tildes (~~~~). Put new text under old text. Click here to start a new topic. New to Wikipedia? Welcome! Ask questions, get answers. This is not a forum for general discussion about the article's subject.	Be polite Assume good faith No personal attacks Be welcoming	Article policies No original research Neutral point of view Verifiability

	Temozolomide is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start	This article has been rated as start-Class on the quality scale.
Mid	This article has been rated as mid-importance for this Project's importance scale.

Added Temodal, which is the brand name in at least Canada and the UK.

This article may be too technical for most readers to understand, and needs attention from an expert on its subject. Please expand it to make it accessible to non-experts, without removing the technical details.

Whoa, go easy on the jargon, Doc... a couple of links would help already, and perhaps more introduction/explanation. --IByte 13:52, 10 January 2007 (UTC)

I would suggest adding Glioblastoma Multiforme as an indication. See http://virtualtrials.com/news3.cfm?item=3052 for proof - the FDA added that in 2005.

I would also suggest adding a link to my website section on Temodar: http://virtualtrials.com/temodar which has the most extensive collection of articles and information on Temodar - including a dosage calculator. Musella (talk) 14:09, 28 May 2008 (UTC)